See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for Phil Wells
Updated daily
Loading publication list...
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 1 | 37452732 | 0 | van Es N, Takada T, Kraaijpoel N, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023 Jul 15:ehad417. doi: 10.1093/eurheartj/ehad417. |
| 2 | 37121015 | 0 | Potere N, Di Nisio M, Porreca E, et al. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015. |
| 3 | 35660801 | 0 | Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014. |
| 4 | 34904857 | 0 | Stals MAM, Takada T, Kraaijpoel N, et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis. Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-2625. |
| 5 | 34715510 | 0 | Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012. |
| 6 | 32685588 | 0 | Peacock WF, Coleman CI, Wells P, et al. Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. J Health Econ Outcomes Res. 2019 Oct 2;6(3):160-173. doi: 10.36469/9936. eCollection 2019. |
| 7 | 32433797 | 0 | Takada T, van Doorn S, Parpia S, et al. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis. J Thromb Haemost. 2020 Sep;18(9):2245-2252. doi: 10.1111/jth.14900. Epub 2020 Jul 8. |
| 8 | 32333946 | 0 | Ashley J, McArthur E, Bota S, et al. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22. |
| 9 | 30729377 | 0 | Wells P, Peacock WF, Fermann GJ, et al. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul;48(1):149-157. doi: 10.1007/s11239-019-01814-z. |
| 10 | 29016692 | 0 | Wang L, Baser O, Wells P, et al. Benefit of early discharge among patients with low-risk pulmonary embolism. PLoS One. 2017 Oct 10;12(10):e0185022. doi: 10.1371/journal.pone.0185022. eCollection 2017. |
, McMaster University